Sammed available for 2024 H2 Marketing Report Submission – Ensure Compliance for 2025

The Executive Secretariat of the Medicines Market Regulation Chamber (SCMED) has informed that the Medicines Market Monitoring System (Sammed) will be available from next week for the submission of the marketing report convering the second half of 2024.

Deadline for submission

The deadline for submitting the report will be between 00:01 a.m. on Monday, February 3, and 11:59 p.m. on March 14, 2025. It is important to note that reports submitted after this deadline will not be accepted.

Importance of submitting on time

Only companies that submit the report on time will be entitled to the maximum adjustment of drug prices in 2025, according to CMED Communiqué No. 11 of August 12, 2015.

How to Submit

Shipments must be made exclusively through Sammed. To ensure that the process is carried out correctly, consult the Commercialization Report Manual, which contains all the guidelines on filling in and sending the report.

If you have any questions, please contact Anvisa at sammed@anvisa.gov.br. To speed up the service, don’t forget to include the following in the message title: [SCMEDCOMERCIALIZAÇÃO-2025-2s2024-DÚVIDA].

In addition, Anvisa’s other service channels are also available to answer additional questions. Make sure your company is compliant for the price adjustment in 2025!

If you have any questions regarding compliance – ELS Group can help!

Please contact your local ELS consultant or email us at info@elssolutions.pt.

ELS Group

ELS Group brings together a team of highly specialized professionals with proven experience in regulatory frameworks and compliance in the pharmaceutical field.

Strategic consulting for the pharmaceutical, healthcare, food, and medtech industries.

Rely on experts to support your regulatory decisions and accelerate the growth of your products safely and efficiently.

Strategic consulting for the pharmaceutical, healthcare, food, and medtech industries.

Experts in pharmaceutical consulting, regulatory strategy, and market access to support your company with safety, compliance, and efficiency. Talk to a consultant.